Literature DB >> 26136968

Effect of elastin-derived peptides on the production of tissue inhibitor of metalloproteinase-1, -2, and -3 and the ratios in various endothelial cell lines.

Krzysztof Siemianowicz1, Wirginia Likus1, Tomasz Francuz1, Wojciech Garczorz1.   

Abstract

Tissue inhibitors of metalloproteinases (TIMPs) control the activity of metalloproteinases. Elastin-derived peptides (EDPs) are generated as a result of the degradation of elastin fibers. The EDPs bind to the elastin receptor and exert numerous biological effects. The aim of the present study was to compare the production of TIMP-1, TIMP-2 and TIMP-3 and their ratios in human endothelial cells (ECs) derived from three clinically important vascular localizations (coronary arteries, aorta and iliac artery), and evaluate the influence of a well-known EDP, κ-elastin. The highest concentration of TIMP-1 was identified in the aortic ECs, while the lowest concentration was observed in the ECs derived from the coronary artery. The opposite pattern was observed for TIMP-2 production. When the TIMP-3 concentration was analyzed in the three EC lines, no statistically significant differences were observed. Application of κ-elastin was found to decrease the TIMP-1 concentration in the aortic ECs, while an increase in the TIMP-1 concentration was observed in the ECs derived from the iliac artery. The most significant decrease in TIMP-2 concentration following κ-elastin administration was observed in the ECs obtained from the coronary arteries. Furthermore, the highest concentration of κ-elastin resulted in an increase in TIMP-3 production in the ECs derived from the coronary arteries. The following ratios of the TIMP concentrations were calculated: TIMP-1/TIMP-2, TIMP-1/TIMP-3 and TIMP-2/TIMP-3. Each ratio presented different values for the ECs obtained from the various localizations. In the majority of cases, the addition of κ-elastin did not significantly change these proportions. Therefore, these indicators may be characteristic features that can be used to describe ECs in various clinically important vascular localizations.

Entities:  

Keywords:  elastin-derived peptides; endothelium; tissue inhibitor of metalloproteinase

Year:  2015        PMID: 26136968      PMCID: PMC4473351          DOI: 10.3892/etm.2015.2429

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  32 in total

1.  Chronic hyperhomocysteinemia causes vascular remodelling by instigating vein phenotype in artery.

Authors:  Poulami Basu; Natia Qipshidze; Utpal Sen; Srikanth Givvimani; Charu Munjal; Paras K Mishra; Suresh C Tyagi
Journal:  Arch Physiol Biochem       Date:  2011-08-13       Impact factor: 4.076

Review 2.  Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

Review 3.  Matrix metalloproteinases: useful and deleterious.

Authors:  E Ganea; M Trifan; A C Laslo; G Putina; C Cristescu
Journal:  Biochem Soc Trans       Date:  2007-08       Impact factor: 5.407

4.  Approach to lipoprotein management in 2001 National Cholesterol Guidelines.

Authors:  Scott M Grundy
Journal:  Am J Cardiol       Date:  2002-10-17       Impact factor: 2.778

5.  Tissue inhibitor of metalloproteinase-2 regulates matrix metalloproteinase-2-mediated endothelial barrier dysfunction and breast cancer cell transmigration through lung microvascular endothelial cells.

Authors:  Qiang Shen; Eugene S Lee; Robert L Pitts; Mack H Wu; Sarah Y Yuan
Journal:  Mol Cancer Res       Date:  2010-06-22       Impact factor: 5.852

6.  Influence of elastin-derived peptides on metalloprotease production in endothelial cells.

Authors:  Krzysztof Siemianowicz; Jan Gminski; Malgorzata Goss; Tomasz Francuz; Wirginia Likus; Teresa Jurczak; Wojciech Garczorz
Journal:  Exp Ther Med       Date:  2010-09-29       Impact factor: 2.447

7.  Analysis of TIMP expression and activity.

Authors:  Linda Troeberg; Hideaki Nagase
Journal:  Methods Mol Med       Date:  2007

8.  Potent inhibition of arterial intimal hyperplasia by TIMP1 gene transfer using AAV vectors.

Authors:  Genaro A Ramirez Correa; Serena Zacchigna; Nikola Arsic; Lorena Zentilin; Alessandro Salvi; Gianfranco Sinagra; Mauro Giacca
Journal:  Mol Ther       Date:  2004-06       Impact factor: 11.454

9.  TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism.

Authors:  Dong-Wan Seo; Hongmei Li; Liliana Guedez; Paul T Wingfield; Tere Diaz; Rita Salloum; Bei-yang Wei; William G Stetler-Stevenson
Journal:  Cell       Date:  2003-07-25       Impact factor: 41.582

10.  Tissue inhibitor of metalloproteinase-1 is an early marker of acute endothelial dysfunction in a rodent model of venous oxidative injury.

Authors:  Rashida Moore; Angela Hawley; Robert Sigler; Diana Farris; Shirley Wrobleski; Eduardo Ramacciotti; Daniel Myers
Journal:  Ann Vasc Surg       Date:  2009-05-21       Impact factor: 1.466

View more
  2 in total

1.  Involvement of TIMP-1 in PECAM-1-mediated tumor dissemination.

Authors:  Valsamma Abraham; Gaoyuan Cao; Andrew Parambath; Fareedah Lawal; Chakkrapong Handumrongkul; Robert Debs; Horace M DeLisser
Journal:  Int J Oncol       Date:  2018-05-25       Impact factor: 5.650

Review 2.  The Elastin Receptor Complex: A Unique Matricellular Receptor with High Anti-tumoral Potential.

Authors:  Amandine Scandolera; Ludivine Odoul; Stéphanie Salesse; Alexandre Guillot; Sébastien Blaise; Charlotte Kawecki; Pascal Maurice; Hassan El Btaouri; Béatrice Romier-Crouzet; Laurent Martiny; Laurent Debelle; Laurent Duca
Journal:  Front Pharmacol       Date:  2016-03-04       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.